Our technology

A revolution in drug discovery & development

Drug development is a complex, time-consuming and resource intensive process that often fails to cross the finish line.

Computer assisted drug design (CADD) has long failed to live up to it's promise to streamline that process and deliver truly insightful information to help design better drugs. HTuO's physics-based technology addresses the root of the issue.

Learn More

Our Mission

Minimizing the error of simulations

For protein scale simulations, it is imperative that the error introduced by approximations in the underlying force field be as small as possible, which is the goal of HTuO’s development process: to get ever closer to accurate simulations with minimal error.

About Us
HtuO Bioscience molecule

The HTuO advantage

Introducing high accuracy into modeling gives us and our partners the ability to address the challenges of drug design head-on. A more detailed understanding of how molecules interact allows for data-driven predictions of the best possible drug design - ultimately leading to fewer drugs failing and more efficacious drugs.

Icon discovery
Target Market

Learn more about our potential in the drug discovery markets.
Technology

Icon discovery
Collaboration

We are happy to discuss partnerships or any other form of collaboration to let you access our platform.
Partnerships

Icon discovery
Careers

We are always on the lookout for talent. We’re open to fixed location and remote work. See Careers

Team Image

Interested in working with us?

Join the HTuO Team

Check our Careers page for open positions, and see if we have the right opportunity for you.

Open Positions

Recent News & Events

January 17th, 2023

We have just released our first white paper, which describes the development of our technology - “Proof of Concept of AtomForge: A Novel Polarizable and Reactive Force Field.” Please email us at info@htuobio.com if you want to read it.

Nov 4, 2022

HTuO Biosciences will be presenting at Life Science BC’s Invest in the West, sponsored by Lumira Ventures. Find us in session 8, where our CEO, Dr. Anthony Fejes, will be presenting and participating in a live Q&A session hosted by LDV Partners.

Nov 2-4, 2022

HTuO Biosciences will be attending the digital partnering component of BIO Europe 2022. If you are in the business of optimizing drugs, we would like to connect with you. Please find us through the partnering platform or email us directly at info@htuobio.com to schedule a meeting.

View All News & Events